KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $43.6 billion.

  • Bristol Myers Squibb's Treasury Shares fell 17.41% to $43.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $43.6 billion, marking a year-over-year decrease of 17.41%. This contributed to the annual value of $43.6 billion for FY2025, which is 17.41% down from last year.
  • As of Q4 2025, Bristol Myers Squibb's Treasury Shares stood at $887.0 million, which was down 78.3% from $887.0 million recorded in Q3 2025.
  • Bristol Myers Squibb's Treasury Shares' 5-year high stood at $902.0 million during Q4 2023, with a 5-year trough of $7.0 million in Q3 2021.
  • Over the past 5 years, Bristol Myers Squibb's median Treasury Shares value was $860.5 million (recorded in 2023), while the average stood at $729.3 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 2936.87% in 2022, then fell by 25.36% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Treasury Shares stood at $31.3 billion in 2021, then rose by 23.54% to $38.6 billion in 2022, then rose by 13.33% to $43.8 billion in 2023, then decreased by 0.25% to $43.7 billion in 2024, then fell by 0.17% to $43.6 billion in 2025.
  • Its Treasury Shares stands at $43.6 billion for Q4 2025, versus $43.6 billion for Q3 2025 and $43.6 billion for Q2 2025.